Article Detail - JE Part B
Open Meeting Announcement - MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms - September 13, 2024
Date Posted: August 1, 2024
This article has been published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV)
Noridian Healthcare Solutions will be hosting an Open Public Meeting on September 13, 2024, from 1 p.m. to 3 p.m. CT.
Advance registration is required.
- Registration deadline to present comments on an LCD will close on September 6, 2024, at 11:59 pm CDT.
- General Registration deadline to participate by listen-only mode will close on September 12, 2024, at 11:59 pm CDT.
Proposed Local Coverage Determination (LCD) and Local Coverage Article (LCA)
- MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms DL39923
- Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms DA59835
View meeting details and register now from the Open Meeting webpage.